DRKS00023710已完成未知
Infectious Diseases Consultation Servives in combination with Antibiotic Stewardship Activities in German Non-University Hospitals - ID-ROLL-OUT
Abteilung Infektiologie, Klinik für Innere Medizin II, Department Innere Medizin, Universiätsklinikum Freiburg0 个研究点目标入组 945 人开始时间: 2021年4月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 945
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •one of the two indicator diseases (S. aureus bacteremia [SAB], outpatient acquired pneumonia [CAP])
排除标准
- •Existence of incomplete data regarding indicator diseases.
- •Regarding CAP: no new/admitted infiltrate, younger 18 years, neutropenia (<500 neutrophils/ul), steroid daily dose (>20mg prednisone equivalent), recent organ transplant, recent autologous/allogeneic stem cell transplant, HIV infection (viral load>20Cop/ml), symptom onset >48 hours after hospitalisation, hospitalisation within 30 days prior to presentation to physician, pneumonia diagnosis >48 hours after endotracheal intubation, COVID-19 infection, patient in psychiatric care.
- •Regarding SAB: younger 18 years, proven s.aureus bacteraemia, patient in psychiatric care, palliative therapy concept, deceased within 48 hours after hospitalisation.
研究者
相似试验
招募中
不适用
Impact of Infectious Diseases Consultation Services on Patient Management and Outcomeall hospitalized patients receiving a consultation report by a specialist for infectious diseasesDRKS00027299Abteilung Infektiologie, Medizinische Klinik II, Universitätsklinik Freiburg3,000
尚未招募
1 期
A prospective covid-19 cohort study of Jingyin granule in the treatment of mild and asymptomatic infections in patients with new crown pneumoniacovid-19ITMCTR2200005862Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
尚未招募
1 期
A prospective covid-19 cohort study of Zheng Qi tablet in the treatment of mild and asymptomatic infections in patients with new crown pneumoniacovid-19ITMCTR2200005863Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
尚未招募
不适用
A randomized, double-blind, low dose controlled clinical trial of Jingyin granule in the treatment of asymptomatic infection in covid-19.ITMCTR2200005865Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
尚未招募
1 期
A multicenter, prospective cohort study of Jingyin Qinghua Fang in treating mild patients with COVID-19 diseasecovid-19ITMCTR2200005864Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine